| 000 | 01891 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517100440.0 | ||
| 264 | 0 | _c20170216 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a1435-4373 | ||
| 024 | 7 |
_a10.1007/s10096-016-2696-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSerra-Pladevall, J | |
| 245 | 0 | 0 |
_aNeisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cSep 2016 |
||
| 300 |
_a1549-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 | _aCephalosporin Resistance |
| 650 | 0 | 4 |
_aCephalosporins _xpharmacology |
| 650 | 0 | 4 | _aDisk Diffusion Antimicrobial Tests |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 |
_aGonorrhea _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Typing |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeisseria gonorrhoeae _xdrug effects |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 |
_aSpain _xepidemiology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBarberá, M J | |
| 700 | 1 | _aRodriguez, S | |
| 700 | 1 | _aBartolomé-Comas, R | |
| 700 | 1 | _aRoig, G | |
| 700 | 1 | _aJuvé, R | |
| 700 | 1 | _aAndreu, A | |
| 773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 35 _gno. 9 _gp. 1549-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10096-016-2696-7 _zAvailable from publisher's website |
| 999 |
_c26084976 _d26084976 |
||